US5142056A
(en)
|
1989-05-23 |
1992-08-25 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
CS263951B1
(en)
|
1985-04-25 |
1989-05-12 |
Antonin Holy |
9-(phosponylmethoxyalkyl)adenines and method of their preparation
|
AU613592B2
(en)
|
1986-11-18 |
1991-08-08 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
|
US5650510A
(en)
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
AU8092587A
(en)
|
1986-11-18 |
1988-05-19 |
Bristol-Myers Squibb Company |
Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
|
JP3347723B2
(ja)
|
1990-06-13 |
2002-11-20 |
グラツィエル,アーノルド |
含リンプロドラッグ
|
DE10399025I2
(de)
|
1990-09-14 |
2007-11-08 |
Acad Of Science Czech Republic |
Wirkstoffvorläufer von Phosphonaten
|
GB9026164D0
(en)
|
1990-12-01 |
1991-01-16 |
Beecham Group Plc |
Pharmaceuticals
|
GB9205917D0
(en)
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
US5278153A
(en)
|
1992-05-18 |
1994-01-11 |
E. R. Squibb & Sons, Inc. |
Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method
|
US5849905A
(en)
|
1994-11-23 |
1998-12-15 |
Centre National De La Recherche Scientifique |
Biologically active phosphotriester-type nucleosides and methods for preparing same
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
AU5018893A
(en)
|
1992-08-17 |
1994-03-15 |
Alcon Laboratories, Inc. |
Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
|
GB9226879D0
(en)
|
1992-12-23 |
1993-02-17 |
Iaf Biochem Int |
Anti-viral compounds
|
US6005107A
(en)
|
1992-12-23 |
1999-12-21 |
Biochem Pharma, Inc. |
Antiviral compounds
|
IL108524A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Imidazodiazepine analogs
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
AU690587B2
(en)
|
1993-09-17 |
1998-04-30 |
Gilead Sciences, Inc. |
Method for dosing therapeutic compounds
|
JP4086314B2
(ja)
|
1993-09-17 |
2008-05-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヌクレオチドアナログ
|
US5659023A
(en)
|
1995-02-01 |
1997-08-19 |
Gilead Sciences, Inc. |
Nucleotide analogues
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
JPH08328191A
(ja)
|
1995-05-31 |
1996-12-13 |
Konica Corp |
ハロゲン化銀写真感光材料
|
WO1997013507A1
(en)
|
1995-10-11 |
1997-04-17 |
Avicena Group, Inc. |
Use of creatine analogues for the treatment of disorders of glucose metabolism
|
US5998457A
(en)
|
1995-10-26 |
1999-12-07 |
Avicena Group, Inc. |
Creatine analogues for treatment of obesity
|
US6228861B1
(en)
|
1995-11-16 |
2001-05-08 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
WO1997017969A1
(en)
|
1995-11-16 |
1997-05-22 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
EP0874858A1
(en)
|
1995-12-29 |
1998-11-04 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5717095A
(en)
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
WO1997035855A1
(en)
|
1996-03-25 |
1997-10-02 |
Smithkline Beecham Corporation |
Novel treatment for cns injuries
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
US5874577A
(en)
|
1996-04-03 |
1999-02-23 |
Medichem Research, Inc. |
Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
|
WO1998004569A1
(en)
|
1996-07-26 |
1998-02-05 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5733788A
(en)
|
1996-07-26 |
1998-03-31 |
Gilead Sciences, Inc. |
PMPA preparation
|
DE19637019A1
(de)
|
1996-09-12 |
1998-03-19 |
Bayer Ag |
Nickel-Katalysatoren für die Polymerisation
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
DE19653646A1
(de)
|
1996-12-20 |
1998-06-25 |
Hoechst Ag |
Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
|
DE19712248A1
(de)
|
1997-03-24 |
1998-10-01 |
Basf Ag |
Verfahren zur Derivatisierung ethylenisch ungesättigter Polyermisate in wässriger Dispersion
|
SG106656A1
(en)
|
1997-07-25 |
2004-10-29 |
Gilead Sciences Inc |
Nucleotide analog composition and synthesis method
|
ATE277936T1
(de)
|
1997-07-25 |
2004-10-15 |
Gilead Sciences Inc |
Verfahren zur herstellung von adefovir dipivoxil
|
WO1999041277A1
(fr)
|
1998-02-17 |
1999-08-19 |
Nippon Kayaku Kabushiki Kaisha |
Nouveau derive d'acetamide et son utilisation
|
ES2401070T3
(es)
|
1998-03-06 |
2013-04-16 |
Metabasis Therapeutics, Inc. |
Nuevos profármacos para compuestos que contienen fósforo
|
MA26634A1
(fr)
|
1998-06-04 |
2004-12-20 |
Astra Ab |
Nouveaux derives de l'acide 3-aryl propionique et analogues
|
WO2000014095A1
(en)
|
1998-09-09 |
2000-03-16 |
Metabasis Therapeutics, Inc. |
Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
|
DE59905623D1
(de)
|
1998-09-22 |
2003-06-26 |
Degussa |
Verfahren zur Herstellung von Imidazolidin-2,4-dionen
|
GB9821058D0
(en)
|
1998-09-28 |
1998-11-18 |
Univ Cardiff |
Chemical compound
|
US6756360B1
(en)
|
1998-12-24 |
2004-06-29 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
CZ20012353A3
(cs)
|
1998-12-24 |
2001-12-12 |
Metabasis Therapeutics, Inc. |
Farmaceutický prostředek obsahující kombinaci inhibitoru FBPázy a senzibilizátoru insulinu
|
JP2001031690A
(ja)
|
1999-05-17 |
2001-02-06 |
Kohjin Co Ltd |
ジモルホリデイト誘導体
|
JP2001031691A
(ja)
|
1999-05-17 |
2001-02-06 |
Kohjin Co Ltd |
9−(2−ホスホニルメトキシアルキル)アデニンの製造法
|
US6248884B1
(en)
|
1999-06-03 |
2001-06-19 |
The Perkin-Elmer Corporation |
Extended rhodamine compounds useful as fluorescent labels
|
US6756382B2
(en)
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6451810B1
(en)
|
1999-06-10 |
2002-09-17 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
EP1065207A1
(en)
|
1999-07-02 |
2001-01-03 |
Aventis Pharma Deutschland GmbH |
Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
|
US6465649B1
(en)
|
1999-08-18 |
2002-10-15 |
Gilead Sciences, Inc. |
Methods for the dealkylation of phosphonate esters
|
DE19953136A1
(de)
|
1999-11-04 |
2001-05-10 |
Aventis Cropscience Gmbh |
Benzoylcyclohexandione und Benzoylpyrazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
JP2003519232A
(ja)
|
2000-01-07 |
2003-06-17 |
ウニフェルジテーレ・インステリング・アントウェルペン |
プリン誘導体、その製造法およびその使用
|
US6797504B1
(en)
|
2000-09-08 |
2004-09-28 |
Dendreon San Diego Llc |
Inhibitors of serine protease activity of matriptase or MTSP1
|
ATE350385T1
(de)
|
2000-03-08 |
2007-01-15 |
Metabasis Therapeutics Inc |
Neue aryl fructose-1,6-bisphosphatase inhibitoren
|
US6768008B2
(en)
|
2000-04-24 |
2004-07-27 |
Aryx Therapeutics |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
US6958355B2
(en)
|
2000-04-24 |
2005-10-25 |
Aryx Therapeutics, Inc. |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
EP1294752A2
(en)
|
2000-06-16 |
2003-03-26 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
WO2002003978A2
(en)
|
2000-07-06 |
2002-01-17 |
Metabasis Therapeutics, Inc. |
A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES
|
US7045309B2
(en)
|
2000-07-07 |
2006-05-16 |
The Research Foundation Of State University Of New York |
9-substituted adenine derivatives as prodrug regulators of cell and tissue function
|
FR2812646A1
(fr)
|
2000-08-04 |
2002-02-08 |
Rhodia Chimie Sa |
Composition polyisocyanate obtenue par polymerisation de monomeres isocyanates et composes polyisocyanates masques
|
US7157596B2
(en)
|
2000-09-08 |
2007-01-02 |
Dendreon Corporation |
Inhibitors of serine protease activity of matriptase or MTSP1
|
US7517892B2
(en)
|
2000-09-11 |
2009-04-14 |
Sepracor Inc. |
Ligands for monoamine receptors and transporters, and methods of use thereof
|
US7294637B2
(en)
|
2000-09-11 |
2007-11-13 |
Sepracor, Inc. |
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
|
MY141789A
(en)
|
2001-01-19 |
2010-06-30 |
Lg Chem Investment Ltd |
Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
|
EP3231445A1
(en)
|
2001-05-18 |
2017-10-18 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
JPWO2002096892A1
(ja)
|
2001-05-31 |
2004-09-09 |
小野薬品工業株式会社 |
オキサジアゾール誘導体化合物およびその化合物を有効成分とする薬剤
|
JP2005509594A
(ja)
|
2001-07-13 |
2005-04-14 |
バーチャル ドラッグ ディヴェロップメント、インコーポレイティッド |
Nadシンテターゼ阻害剤およびその使用
|
US20030073681A1
(en)
|
2001-08-21 |
2003-04-17 |
Hauske James R. |
2-substituted piperidines that are ligands for monoamine receptors and transporters
|
FR2829137B1
(fr)
|
2001-08-28 |
2003-12-19 |
Rhodia Chimie Sa |
Procede de polymerisation radicalaire realise en presence de composes disulfures
|
AU2002365935A1
(en)
|
2001-11-14 |
2003-10-27 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
|
GB0129945D0
(en)
|
2001-12-13 |
2002-02-06 |
Mrc Technology Ltd |
Chemical compounds
|
US7649015B2
(en)
|
2002-04-26 |
2010-01-19 |
Gilead Sciences, Inc. |
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
|
EP1504014B1
(en)
|
2002-05-13 |
2015-12-02 |
Metabasis Therapeutics, Inc. |
Process for preparation of cyclic prodrugs of pmea and pmpa
|
EP2223927B1
(en)
|
2002-05-13 |
2014-10-15 |
Metabasis Therapeutics, Inc. |
Salts of a phosphonic acid based prodrug of PMEA
|
US6825348B2
(en)
|
2002-06-25 |
2004-11-30 |
Academia Sinica |
Antiviral compounds
|
CN1465582A
(zh)
|
2002-07-01 |
2004-01-07 |
中国人民解放军军事医学科学院放射医 |
核苷酸类似物、含它的药物组合物及其用途
|
FR2844264B1
(fr)
|
2002-09-11 |
2006-10-20 |
Rhodia Chimie Sa |
Nouveaux composes comprenant un groupement thiocarbonylsulfanyle utiles pour la synthese de composes alpha-perfluoroalkylamines par voie radicalaire
|
WO2004029064A1
(en)
|
2002-09-26 |
2004-04-08 |
Lg Life Sciences Ltd. |
(+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
|
EP1578754A4
(en)
|
2002-10-30 |
2006-07-19 |
Makscientific Llc |
ROTARY PHOSPHOLIPIDS SUBSTITUTED ANTIPROTOZOOSES
|
CN1425680A
(zh)
|
2002-12-27 |
2003-06-25 |
李志海 |
核苷酸类似物组合物及制备方法
|
CN1523028A
(zh)
|
2003-02-18 |
2004-08-25 |
田镇华 |
一种新型的膦酸酯-核苷酸化合物
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
GB0311406D0
(en)
|
2003-05-17 |
2003-06-25 |
Queen Mary & Westfield College |
Substituted phosphonate fluorescent sensors,and use thereof
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
AU2004260789B2
(en)
|
2003-07-30 |
2011-06-30 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
DE10337761A1
(de)
|
2003-08-14 |
2005-03-17 |
Bioagency Ag |
Phosphororganische 4-Iminohydantoinderivate
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
FR2861726B1
(fr)
|
2003-11-04 |
2006-03-10 |
Rhodia Cons Spec Ltd |
Procede diastereoselectif de preparation d'olefines par la reaction d'horner-wadsworth-emmons mettant en oeuvre un phosphonate particulier qui ameliore la diastereoselectivite a toutes temperatures y compris a temperature ambiante
|
US7834043B2
(en)
|
2003-12-11 |
2010-11-16 |
Abbott Laboratories |
HIV protease inhibiting compounds
|
WO2005058330A1
(en)
|
2003-12-17 |
2005-06-30 |
Quatrx Pharmaceuticals Co. |
Phosphorus containing compounds useful for the regulation of ldl and lp(a) levels
|
PL2204374T3
(pl)
|
2003-12-30 |
2012-11-30 |
Gilead Sciences Inc |
Fosfoniany nukleozydów i ich analogi do leczenia zakażeń HPV
|
JP2007523180A
(ja)
|
2004-02-17 |
2007-08-16 |
エルジー・ライフ・サイエンシーズ・リミテッド |
Hiv感染治療に有用なヌクレオシドホスホネート誘導体
|
FR2867187B1
(fr)
|
2004-03-02 |
2007-10-12 |
Centre Nat Rech Scient |
Procede utile pour la preparation de benzazepines et derives de celles-ci.
|
WO2005087788A2
(en)
|
2004-03-04 |
2005-09-22 |
The Regents Of The University Of California |
Methods for preparation of nucleoside phosphonate esters
|
US7378532B2
(en)
|
2004-03-26 |
2008-05-27 |
Yung Shin Pharmaceutical Ind. Co., Ltd. |
Fused pyrazolyl compound
|
KR20070029196A
(ko)
|
2004-06-08 |
2007-03-13 |
메타베이시스 테라퓨틱스, 인크. |
고리 에스테르의 루이스 산 매개 합성
|
CN100338080C
(zh)
|
2004-06-16 |
2007-09-19 |
山东中科泰斗化学有限公司 |
9-[2-(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
ITFI20040173A1
(it)
|
2004-08-03 |
2004-11-03 |
Protera S R L |
Profarmaci attivati da dna polimerasi dipendenti da rna
|
JP4590228B2
(ja)
|
2004-08-17 |
2010-12-01 |
富士フイルム株式会社 |
インク組成物、インクジェット用インク及びインクジェット用インクセット
|
CN1634943A
(zh)
|
2004-11-05 |
2005-07-06 |
中国医学科学院医药生物技术研究所 |
一组非环核苷酸类似物及其合成方法和在抗病毒中的应用
|
US7517870B2
(en)
|
2004-12-03 |
2009-04-14 |
Fondazione Telethon |
Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
|
CN1796393A
(zh)
|
2004-12-24 |
2006-07-05 |
博瑞生物医药技术(苏州)有限公司 |
核苷酸类似物
|
WO2006102594A1
(en)
|
2005-03-23 |
2006-09-28 |
Genelabs Technologies, Inc. |
Nucleoside prodrugs for treating viral infections
|
WO2007084157A2
(en)
|
2005-03-23 |
2007-07-26 |
Genelabs Technologies, Inc. |
Nucleoside prodrugs for treating viral infections
|
WO2006130217A2
(en)
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
WO2006114064A2
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
FR2884823A1
(fr)
|
2005-04-26 |
2006-10-27 |
Rhodia Chimie Sa |
Procede de procede d'adenine hydroxypropylenee optiquement active
|
CN102240296B
(zh)
|
2005-06-13 |
2013-04-03 |
博瑞生物医药技术(苏州)有限公司 |
泰诺福韦的固体
|
WO2007002808A1
(en)
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-nonmelanoma carcinoma compounds, compositions, and methods of use thereof
|
WO2007002912A2
(en)
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-proliferative compounds, compositions, and methods of use thereof
|
EP1910352A1
(en)
|
2005-07-20 |
2008-04-16 |
Merck Frosst Canada Ltd. |
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
WO2007013085A1
(en)
|
2005-07-26 |
2007-02-01 |
Hetero Drugs Limited |
Novel process for acyclic phosphonate nucleotide analogs
|
WO2007013086A1
(en)
|
2005-07-26 |
2007-02-01 |
Hetero Drugs Limited |
Novel polymorphs of tenofovir disoproxil fumarate
|
WO2007014352A2
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
AP2008004459A0
(en)
|
2005-10-06 |
2008-06-30 |
Univ Massachusetts |
Composition and sythesis of new reagents for inhibition of HIV replication
|
CN1947796B
(zh)
*
|
2005-10-13 |
2010-11-24 |
江苏正大天晴药业股份有限公司 |
化学修饰的阿德福韦或泰诺福韦
|
CN1966514A
(zh)
|
2005-11-14 |
2007-05-23 |
北京美倍他药物研究有限公司 |
新的无环核苷膦酸酯及其医药用途
|
CN100567315C
(zh)
|
2005-12-19 |
2009-12-09 |
北京美倍他药物研究有限公司 |
无环核苷膦酸的前体药物
|
WO2007095269A2
(en)
|
2006-02-14 |
2007-08-23 |
Merck & Co., Inc. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
CN101033238B
(zh)
|
2006-03-06 |
2011-02-16 |
中国科学院上海药物研究所 |
嘌呤类化合物双氨基酸酯的制备方法和用途
|
CN100396689C
(zh)
*
|
2006-03-07 |
2008-06-25 |
中国医学科学院医药生物技术研究所 |
一组具有抑制hiv-1/hbv病毒复制活性的替诺福韦单酯化合物
|
US20090131384A1
(en)
|
2006-03-22 |
2009-05-21 |
Syndexa Pharmaceuticals Corporation |
Compounds and methods for treatment of disorders associated with er stress
|
JP5320284B2
(ja)
|
2006-05-03 |
2013-10-23 |
キメリクス,インコーポレーテッド |
抗ウイルス性または抗増殖性のホスホネート、ヌクレオシドホスホネートおよびヌクレオシドホスフェートの代謝安定性アルコキシアルキルエステル
|
WO2007128815A1
(en)
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
CN101442994B
(zh)
|
2006-05-16 |
2013-03-06 |
吉里德科学公司 |
用于治疗恶性血液病的方法和组合物
|
WO2007134457A1
(en)
|
2006-05-22 |
2007-11-29 |
Merck Frosst Canada Ltd. |
Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
CN101085785B
(zh)
|
2006-06-06 |
2011-09-21 |
中国科学院上海药物研究所 |
用于治疗乙型肝炎的嘌呤类化合物及其制备方法和用途,以及包括该化合物的组合物
|
JP2009539884A
(ja)
|
2006-06-12 |
2009-11-19 |
メルク フロスト カナダ リミテツド |
ステアロイル−コエンザイムaデルタ−9デサチュラーゼのインヒビターとしてのアゼチジン誘導体
|
EP2032570A4
(en)
|
2006-06-13 |
2010-10-27 |
Merck Frosst Canada Ltd |
AZACYCLOPENTATE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE
|
CN101089004A
(zh)
|
2006-06-13 |
2007-12-19 |
上海舒盟化学科技有限公司 |
一种新型的膦酸酯-核苷酸化合物
|
ES2437871T3
(es)
|
2006-07-07 |
2014-01-14 |
Gilead Sciences, Inc. |
Moduladores del receptor tipo toll 7
|
EP2046792B1
(en)
|
2006-07-12 |
2015-02-25 |
Mylan Laboratories Limited |
Process for the preparation of tenofovir
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
IL178645A0
(en)
|
2006-10-16 |
2007-02-11 |
Ariel University Res And Dev C |
Dendrimeric platform for controlled release of drugs
|
FR2908133B1
(fr)
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
CN101190927B
(zh)
|
2006-11-30 |
2012-04-18 |
天津天士力集团有限公司 |
9-[2-(膦酰甲氧)乙基]腺嘌呤单特戊酰氧甲酯的制备方法
|
CN101190935B
(zh)
|
2006-12-01 |
2012-05-30 |
山东轩竹医药科技有限公司 |
用于病毒性感染的化合物
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
CN101003550B
(zh)
|
2006-12-30 |
2010-05-19 |
河南省分析测试研究中心 |
8-卤代腺嘌呤类核苷化合物、合成方法和其药物用途
|
CL2008000070A1
(es)
|
2007-01-17 |
2008-07-25 |
Lg Life Sciences Ltd |
Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h
|
ES2607901T3
(es)
|
2007-01-31 |
2017-04-04 |
Chongxi Yu |
Profármacos hidrosolubles cargados positivamente de 1H-imidazo[4,5-c]quinolin-4-aminas y compuestos relacionados con ratas de penetración de piel muy altas
|
WO2008096369A2
(en)
|
2007-02-05 |
2008-08-14 |
Matrix Laboratories Limited |
Pharmaceutical formulation for use in hiv therapy
|
WO2010125200A1
(en)
|
2009-04-30 |
2010-11-04 |
Katholieke Universiteit Leuven, K.U. Leuven R&D |
Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral angents
|
WO2008104408A2
(en)
|
2007-02-27 |
2008-09-04 |
K. U. Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
CN101279987A
(zh)
|
2007-04-05 |
2008-10-08 |
江西麒麟化工有限公司 |
泰诺福韦生产工艺
|
WO2008134578A2
(en)
|
2007-04-28 |
2008-11-06 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
Synthesis of optically active radio-labeled reverse transcriptase inhibitors
|
CN101066980A
(zh)
|
2007-05-08 |
2007-11-07 |
黑龙江加州国际投资咨询有限公司 |
富马酸泰诺福韦酯新晶型及其药用制剂
|
WO2008140302A1
(en)
|
2007-05-14 |
2008-11-20 |
Ultimorphix Technologies B.V. |
Polymorphic forms of tenofovir disoproxil fumarate
|
US20090270352A1
(en)
|
2007-05-22 |
2009-10-29 |
Ultimorphix Technologies B.V. |
Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
|
CN101066981B
(zh)
|
2007-05-25 |
2011-10-05 |
中国科学院上海药物研究所 |
非环核苷膦酸酯类化合物及其组合物、制备方法和用途
|
US20080318904A1
(en)
|
2007-06-20 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched tenofovir
|
US8354421B2
(en)
|
2007-06-29 |
2013-01-15 |
Korea Research Insitute Of Chemical Technology |
HIV reverse transcriptase inhibitors
|
CN106279283A
(zh)
|
2007-08-13 |
2017-01-04 |
症变治疗公司 |
新颖的葡糖激酶活化剂
|
FR2921661B1
(fr)
|
2007-10-01 |
2013-05-31 |
Centre Nat Rech Scient |
Solide hybride organique inorganique a surface modifiee.
|
WO2009046573A1
(fr)
|
2007-10-11 |
2009-04-16 |
Beijing Shiqiao Bio-Pharmaceutical Co., Ltd |
Promédicament adefovir ciblant le foie et son utilisation médicale
|
WO2009052050A1
(en)
|
2007-10-15 |
2009-04-23 |
Pharmasset, Inc. |
Dioxolane thymine phosphoramidates as anti-hiv agents
|
MX2010004487A
(es)
|
2007-10-23 |
2010-05-05 |
Allergan Inc |
Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
|
CN101143879A
(zh)
|
2007-11-08 |
2008-03-19 |
上海交通大学 |
含硫无环核苷膦酸类似物及其制备方法
|
WO2009064174A1
(en)
|
2007-11-14 |
2009-05-22 |
Ultimorphix Technologies B.V. |
Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
|
CN101450954B
(zh)
|
2007-12-05 |
2013-05-08 |
中国人民解放军第二军医大学 |
核苷酸类似物及其应用,以及含该核苷酸类似物的药物组合物
|
CN101918418A
(zh)
|
2007-12-12 |
2010-12-15 |
阿尔迪默菲克斯技术有限责任公司 |
替诺福韦地索普西的固体形式
|
US8119800B2
(en)
|
2007-12-21 |
2012-02-21 |
Korea Research Institute Of Chemical Technology |
Processes for preparing HIV reverse transcriptase inhibitors
|
CN101230065B
(zh)
|
2008-01-23 |
2010-09-15 |
台州市知青化工有限公司 |
一种生产9-〔2(羟基)丙基〕腺嘌呤的方法
|
MX2010008148A
(es)
|
2008-01-25 |
2010-10-20 |
Chimerix Inc |
Métodos de tratamiento de infecciones virales.
|
TWI444384B
(zh)
*
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
CN101531680B
(zh)
|
2008-03-13 |
2011-08-10 |
上海迪赛诺医药发展有限公司 |
合成(r)-9-[2-(二乙基膦酰基甲氧基)丙基]-腺嘌呤的方法
|
CN101531679B
(zh)
|
2008-03-13 |
2013-05-15 |
上海迪赛诺医药发展有限公司 |
制备膦酰基甲氧基核苷酸类似物的方法
|
CN101278938A
(zh)
|
2008-03-20 |
2008-10-08 |
黑龙江加州国际投资咨询有限公司 |
泰诺福韦酯和恩替卡韦的复方制剂及其抗乙肝病毒的应用
|
US8946243B2
(en)
|
2008-03-28 |
2015-02-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and methods for the treatment of viral infection
|
KR20150053816A
(ko)
|
2008-04-25 |
2015-05-18 |
씨아이피엘에이 엘티디. |
테노포비어 디소프록실의 결정형 및 그의 제조방법
|
CN101574356A
(zh)
|
2008-05-07 |
2009-11-11 |
黑龙江加州国际投资咨询有限公司 |
泰诺福韦酯药用盐及其制剂
|
CN101585854B
(zh)
|
2008-05-19 |
2011-10-05 |
中国科学院上海药物研究所 |
一类新的非环核苷膦酸酯类化合物及其组合物、制备方法和用途
|
CN101307076A
(zh)
|
2008-05-30 |
2008-11-19 |
秦引林 |
一种具有肝靶向抗乙肝病毒作用的前药
|
WO2010026603A2
(en)
|
2008-09-05 |
2010-03-11 |
Matrix Laboratories Limited |
Novel amine salts of tenofovir, process for producing the same and use thereof in production of tenofovir dioproxil
|
CN101418017B
(zh)
|
2008-11-12 |
2011-07-20 |
上海奥锐特国际贸易有限公司 |
(r)-9-(2-磷酸甲氧基丙基)腺嘌呤的合成方法
|
CN101591357A
(zh)
|
2008-11-20 |
2009-12-02 |
杜晓敏 |
一组抑制bcr-abl激酶的磷酸/磷酸酯类化合物
|
WO2010068708A2
(en)
|
2008-12-09 |
2010-06-17 |
Rfs Pharma, Llc |
3'-azido purine nucleotide prodrugs for treatment of viral infections
|
CN101759722A
(zh)
|
2008-12-16 |
2010-06-30 |
北京利乐生制药科技有限公司 |
无环核苷膦酸的新型前体药物
|
CN101463045B
(zh)
|
2009-01-07 |
2011-08-31 |
合肥恒星药物研究所 |
硫代膦酸酯核苷酸化合物
|
EP2385951A4
(en)
|
2009-01-09 |
2013-05-29 |
Univ Cardiff |
PHOSPHORAMIDATE DERIVATIVES OF GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS
|
CN101475594B
(zh)
|
2009-02-06 |
2012-05-30 |
廖国超 |
肝靶向抗病毒前体药物环状磷酸酯及其应用
|
WO2010091386A2
(en)
|
2009-02-06 |
2010-08-12 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
FR2943676B1
(fr)
|
2009-03-26 |
2017-03-24 |
Univ De Provence |
Composes biradicalaires de type dinitroxyde optimises pour la polarisation dynamique nucleaire (pdn)
|
CN101906119B
(zh)
|
2009-06-03 |
2012-12-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
制备替诺福韦的新方法
|
WO2010142761A1
(en)
|
2009-06-10 |
2010-12-16 |
Ultimorphix Technologies B.V. |
The succinate of tenofovir disoproxil
|
US8833449B2
(en)
|
2009-07-09 |
2014-09-16 |
3M Innovative Properties Company |
Methods for treating carbonate hydrocarbon-bearing formations with fluorinated amphoteric compounds
|
CN101648974A
(zh)
|
2009-07-21 |
2010-02-17 |
广东京豪医药科技开发有限公司 |
泰诺福韦酯合成新工艺
|
JP2013501056A
(ja)
|
2009-08-03 |
2013-01-10 |
キメリクス,インコーポレイテッド |
ウイルス感染およびウイルス誘発腫瘍を治療する組成物および方法
|
CN101659676B
(zh)
|
2009-09-07 |
2012-06-20 |
徐奎 |
一种硫代阿德福韦、替诺福韦肝靶向酯前体药物
|
WO2011031628A1
(en)
|
2009-09-14 |
2011-03-17 |
Schering Corporation |
Inhibitors of diacylglycerol acyltransferase
|
WO2011038207A1
(en)
|
2009-09-25 |
2011-03-31 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing thyroid hormone receptor agonists and methods of use
|
US20130072458A1
(en)
|
2009-10-30 |
2013-03-21 |
Chimerix, Inc. |
Methods of Treating Viral Associated Diseases
|
CN102070670A
(zh)
|
2009-11-20 |
2011-05-25 |
贵阳医学院 |
一类治疗乙型肝炎的嘌呤类衍生物、其制备方法与用途
|
GB0921443D0
(en)
|
2009-12-08 |
2010-01-20 |
Univ Leuven Kath |
Novel phosph(on)ate-and sulf(on)ate-based phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
CN101712692A
(zh)
|
2009-12-21 |
2010-05-26 |
巢杰 |
泰诺福韦酯的药用酸加成盐及其制备方法和药物应用
|
EP3216789A1
(en)
|
2010-02-12 |
2017-09-13 |
Chimerix, Inc. |
Methods of treating viral infection
|
CN101781334B
(zh)
|
2010-03-04 |
2012-11-28 |
福建广生堂药业股份有限公司 |
替诺福韦酯的盐化合物,其制备方法和药物应用
|
CN101781335B
(zh)
|
2010-03-04 |
2014-01-15 |
福建广生堂药业股份有限公司 |
富马酸替诺福韦酯的晶型及其制备方法
|
EP2545063A2
(en)
|
2010-03-11 |
2013-01-16 |
Matrix Laboratories Ltd |
An improved process for the preparation of tenofovir disoproxil fumarate
|
AU2011239560B2
(en)
|
2010-04-14 |
2016-11-03 |
The Regents Of The University Of California |
Phosphonates with reduced toxicity for treatment of viral infections
|
AR080884A1
(es)
|
2010-04-14 |
2012-05-16 |
Sanofi Aventis |
Conjugados de insulina-sirna
|
WO2011133963A2
(en)
|
2010-04-23 |
2011-10-27 |
University Of Southern California |
Tyrosine-based prodrugs of antiviral agents
|
CN101928302B
(zh)
|
2010-04-29 |
2012-09-12 |
浙江康多利药业有限公司 |
N-苄基-9-[2-(二烷基磷酰基甲氧基)烷基]腺嘌呤及其制备方法和应用
|
CN101870713A
(zh)
|
2010-05-28 |
2010-10-27 |
杭州和素化学技术有限公司 |
一种替诺福韦酯的产业化生产工艺
|
EA201291460A1
(ru)
|
2010-05-28 |
2013-11-29 |
Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем |
Олигобензамидные соединения и их применение
|
CN101985454A
(zh)
|
2010-06-02 |
2011-03-16 |
博瑞生物医药技术(苏州)有限公司 |
泰诺福韦酯马来酸盐新晶型、其制备方法及其制药应用
|
CN101948485B
(zh)
|
2010-08-30 |
2012-07-25 |
杭州和素化学技术有限公司 |
富马酸替诺福韦酯α晶型及其制备方法和应用
|
KR101195631B1
(ko)
|
2010-09-08 |
2012-10-30 |
하나제약 주식회사 |
9-[2-(포스포노메톡시)에틸]아데닌의 개선된 제조방법
|
CN102040626A
(zh)
|
2010-11-05 |
2011-05-04 |
福建广生堂药业有限公司 |
一种泰诺福韦单酯的制备方法及其含量检测方法
|
CN102093417B
(zh)
|
2010-11-15 |
2012-11-28 |
济南久创化学有限责任公司 |
一种可制备核苷膦酸类药物的化合物及其制备方法
|
CN102485229B
(zh)
|
2010-12-02 |
2015-09-02 |
中国人民解放军军事医学科学院毒物药物研究所 |
抗病毒药物
|
RU2606845C2
(ru)
|
2010-12-10 |
2017-01-10 |
СИГМАФАРМ ЛЭБОРЭТОРИЗ, ЭлЭлСи |
Высокостабильные композиции перорально активных аналогов нуклеотидов или перорально активных пролекарств аналогов нуклеотидов
|
CN102060876B
(zh)
|
2010-12-29 |
2014-06-11 |
中山百灵生物技术有限公司 |
一种替诺福韦制备方法
|
US9156874B2
(en)
|
2011-01-03 |
2015-10-13 |
Nanjing Molecular Research, Inc. |
Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
|
WO2012098255A1
(en)
|
2011-01-21 |
2012-07-26 |
Straitmark Holding Ag |
METHOD FOR THE MANUFACTURE OF COMPOUNDS CONTAINING AN α-OXY PHOSPHORUS GROUP
|
MX2013009551A
(es)
|
2011-02-24 |
2013-09-06 |
Jiangsu Hanson Pharmaceutical Co Ltd |
Compuestos que contienen fosforo como inhibidores de proteina cinasa.
|
GB201103526D0
(en)
|
2011-03-02 |
2011-04-13 |
Summit Corp Plc |
Selective glycosidase inhibitors and uses thereof
|
AU2012245082A1
(en)
|
2011-04-20 |
2013-10-24 |
Biota Scientific Management Pty Ltd |
Aromatic amides and uses thereof
|
CN103619817A
(zh)
|
2011-04-28 |
2014-03-05 |
百时美施贵宝公司 |
新颖的二环含氮杂芳基tgr5受体调节剂
|
CN103619854A
(zh)
|
2011-04-29 |
2014-03-05 |
西奈山伊坎医学院 |
激酶抑制剂
|
US9550803B2
(en)
|
2011-05-06 |
2017-01-24 |
University Of Southern California |
Method to improve antiviral activity of nucleotide analogue drugs
|
CN102276667A
(zh)
|
2011-06-24 |
2011-12-14 |
淮阴工学院 |
高效抗肝癌的白藜芦醇前药及合成方法
|
US9334300B2
(en)
|
2011-08-01 |
2016-05-10 |
Mbc Pharma, Inc. |
Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
TWI689513B
(zh)
|
2011-10-07 |
2020-04-01 |
美商基利科學股份有限公司 |
抗病毒核苷酸類似物的製備方法
|
US8835493B2
(en)
|
2011-11-23 |
2014-09-16 |
Board Of Regents, The University Of Texas System |
Oligo-benzamide compounds for use in treating cancers
|
WO2013078277A1
(en)
|
2011-11-23 |
2013-05-30 |
The Board Of Regents Of The University Of Texas System |
Oligo-benzamide compounds and their use in treating cancers
|
US20130244966A1
(en)
|
2011-12-12 |
2013-09-19 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid antiviral conjugates and their uses
|
JP6113185B2
(ja)
|
2011-12-22 |
2017-04-12 |
ジェロン・コーポレーションGeron Corporation |
テロメラーゼ基質およびテロメア長作用因子としてのグアニンアナログ
|
US20150105350A1
(en)
|
2012-02-03 |
2015-04-16 |
Gilead Sciences, Inc. |
Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
|
AU2012327170A1
(en)
|
2012-02-03 |
2013-08-22 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
EP2846788A1
(en)
|
2012-05-11 |
2015-03-18 |
Akron Molecules AG |
Use of compounds for the treatment of pain
|
GB201209244D0
(en)
|
2012-05-25 |
2012-07-04 |
Globalacorn Ltd |
Compositions
|
CN104640444B
(zh)
|
2012-06-16 |
2016-12-14 |
河南美泰宝生物制药有限公司 |
双肝脏靶向氨基磷酸酯和氨基膦酸酯前药
|
GB201215696D0
(en)
|
2012-09-03 |
2012-10-17 |
Ithemba Pharmaceuticals Pty Ltd |
A process for the preparation of (R)-9-[2-(Phosphonometh-Oxy)propyl]adenine (PMPA)
|
CN104884462A
(zh)
|
2012-10-29 |
2015-09-02 |
共晶制药股份有限公司 |
用于治疗病毒感染和癌症的嘧啶核苷及其单磷酸酯前药
|
US9227990B2
(en)
|
2012-10-29 |
2016-01-05 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
CN103845345A
(zh)
|
2012-12-03 |
2014-06-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
肝炎治疗药物
|
BR112015012455A2
(pt)
|
2012-12-06 |
2017-07-11 |
Merck Sharp & Dohme |
composto, e, uso de uma quantidade terapeuticamente efetiva de pelo menos um composto, ou um sal, solvato, éster ou pró-droga farmaceuticamente aceitáveis de um composto ou composição
|
WO2014099578A1
(en)
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Novel glucokinase activator compounds, compositions containing such compounds, and methods of treatment
|
CN103923124A
(zh)
|
2013-01-15 |
2014-07-16 |
中国人民解放军军事医学科学院毒物药物研究所 |
结晶态的抗乙肝病毒药物
|
CN107714683A
(zh)
|
2013-03-06 |
2018-02-23 |
阿勒根公司 |
用于治疗皮肤病的甲酰基肽受体2的激动剂的用途
|
US9850264B2
(en)
|
2013-03-06 |
2017-12-26 |
Allergan, Inc. |
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
|
US20140288025A1
(en)
|
2013-03-13 |
2014-09-25 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid antiviral conjugates and their uses
|
CN107056838A
(zh)
|
2013-03-15 |
2017-08-18 |
加利福尼亚大学董事会 |
无环核苷膦酸二酯
|
CN104072539B
(zh)
|
2013-03-25 |
2017-03-29 |
安徽贝克联合制药有限公司 |
替诺福韦双(4‑乙酰氨基苯酚氧基)酯及其制备方法和其应用
|
US20140315790A1
(en)
|
2013-04-17 |
2014-10-23 |
Simon Bushell |
Aminothiazoles and their uses
|
US20160108031A1
(en)
|
2013-04-30 |
2016-04-21 |
Heinrich-Heine-Universitat Dusseldorf |
Inhibitors of nhr2 and/or runx1/eto-tetramerization
|
CN104151360B
(zh)
|
2013-05-14 |
2019-02-22 |
北京美倍他药物研究有限公司 |
磷酸/膦酸衍生物及其医药用途
|
WO2015040640A2
(en)
|
2013-09-20 |
2015-03-26 |
Laurus Labs Private Limited |
An improved process for the preparation of tenofovir alafenamide or pharmaceutically acceptable salts thereof
|
CN104558035B
(zh)
|
2013-10-22 |
2017-12-19 |
连云港恒运药业有限公司 |
一种替诺福韦前药的纯化方法
|
CN104628773B
(zh)
|
2013-11-06 |
2018-10-23 |
杭州和泽医药科技有限公司 |
(r)-9-[2-(磷酰苯酚基甲氧基)丙基]腺嘌呤的制备方法
|
GB201320962D0
(en)
|
2013-11-27 |
2014-01-08 |
Globalacorn Ltd |
Compositions
|
GB201320959D0
(en)
|
2013-11-27 |
2014-01-08 |
Globalacorn Ltd |
Compositions
|